Key Takeaways
- • University Hospitals appoints Melissa Cohen, MBA, as Vice President of Venture Development and Investment, expanding the health system's innovation and investment capabilities.
- • Cohen brings demonstrated expertise in healthcare innovation, entrepreneurship, and venture capital, with prior experience at Boston Medical Center and involvement in healthcare accelerator programs.
- • The appointment reflects University Hospitals' strategic focus on identifying and partnering with early-stage healthcare and health-adjacent companies, particularly in emerging technology sectors.
- • Cohen's background spans healthcare system leadership, venture investing, and mentorship roles in medical technology acceleration, positioning her to bridge clinical operations and investment strategy.
- • The hire signals continued institutional investment by major health systems in venture development infrastructure, aligning with sector-wide trends toward direct engagement with healthcare innovation ecosystems.
Summary
University Hospitals has named Melissa Cohen, MBA, to the newly emphasized role of Vice President of Venture Development and Investment. This appointment positions Cohen within University Hospitals Ventures, the health system's dedicated venture and innovation arm, where she joins an existing team structure that includes venture leadership focused on identifying and investing in healthcare technology and innovation opportunities.
Cohen arrives with substantial credentials in healthcare innovation and entrepreneurship. Her professional background includes experience at Boston Medical Center and education from The Wharton School, with demonstrated expertise spanning healthcare operations, innovation strategy, and venture capital deployment. Notably, she serves as a mentor within healthcare accelerator programs, including the mHUB MedTech Accelerator, and has held roles as Managing Director within health system venture capital operations, including her involvement with NorthShore – Edward-Elmhurst Venture Capital.
The appointment underscores University Hospitals' institutional commitment to venture development as a core strategic function. Recent activity indicates the organization's active engagement with innovation ecosystems; Cohen has judged the 2026 UH Haslam Sports Innovation Center Challenge, reflecting the health system's expansion into adjacencies like athlete performance technology and augmentation—sectors with direct applicability to clinical healthcare innovation. Her assessment of this space highlights the strategic crossover potential where performance technology increasingly intersects with mainstream healthcare applications.
This hire reflects broader sector patterns wherein major health systems have elevated venture capital, innovation partnerships, and early-stage company engagement from peripheral initiatives to core institutional functions. By formalizing venture development leadership, University Hospitals positions itself to systematically evaluate, partner with, and potentially invest in healthcare-adjacent innovation, creating both strategic optionality and potential financial returns through early-stage company participation.
Cohen arrives with substantial credentials in healthcare innovation and entrepreneurship. Her professional background includes experience at Boston Medical Center and education from The Wharton School, with demonstrated expertise spanning healthcare operations, innovation strategy, and venture capital deployment. Notably, she serves as a mentor within healthcare accelerator programs, including the mHUB MedTech Accelerator, and has held roles as Managing Director within health system venture capital operations, including her involvement with NorthShore – Edward-Elmhurst Venture Capital.
The appointment underscores University Hospitals' institutional commitment to venture development as a core strategic function. Recent activity indicates the organization's active engagement with innovation ecosystems; Cohen has judged the 2026 UH Haslam Sports Innovation Center Challenge, reflecting the health system's expansion into adjacencies like athlete performance technology and augmentation—sectors with direct applicability to clinical healthcare innovation. Her assessment of this space highlights the strategic crossover potential where performance technology increasingly intersects with mainstream healthcare applications.
This hire reflects broader sector patterns wherein major health systems have elevated venture capital, innovation partnerships, and early-stage company engagement from peripheral initiatives to core institutional functions. By formalizing venture development leadership, University Hospitals positions itself to systematically evaluate, partner with, and potentially invest in healthcare-adjacent innovation, creating both strategic optionality and potential financial returns through early-stage company participation.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.